BIM
NVO

Brentview Investment Management’s Novo Nordisk NVO Stock Holding History

Brentview Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.8K Hold
2,334
– – 0.04% 44
2025
Q4 		$119K Hold
2,334
– – 0.05% 43
2025
Q3 		$130K Hold
2,334
– – 0.06% 42
2025
Q2 		$161K Hold
2,334
– – 0.08% 42
2025
Q1 		$162K Hold
2,334
– – 0.09% 42
2024
Q4 		$201K Buy
+2,334
New +$252K 0.11% 40

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Brentview Investment Management's NVO Position: Q1 2026 in Review

Brentview Investment Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 2,334 shares worth $85.8K. The position accounts for 0.04% of the portfolio, ranked #44.

Brentview Investment Management first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $201K in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Brentview Investment Management held 2,334 shares of Novo Nordisk worth $85.8K as of Q1 2026.
  • Brentview Investment Management left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up 0.04% of Brentview Investment Management's portfolio in Q1 2026, its #44 holding.
  • Brentview Investment Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • Brentview Investment Management's Novo Nordisk position peaked at $201K in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Brentview Investment Management's 13F filing for Q1 2026, filed 14 May 2026.